X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2018 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare, Analyse TTK HEALTHCARE with ACTAVIS INC. - US - Equitymaster
  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

TTK HEALTHCARE vs ACTAVIS (US) - Comparison Results

ACTAVIS (US)
   Change

Actavis, Inc. is a global, integrated specialty pharmaceutical company focused on developing, manufacturing and distributing generic, brand and biosimilar products. It develops, manufactures and market generic, branded generic, legacy brands and Over... More

DO YOU LIKE THESE REPORTS? TELL US!

Financials

 TTK HEALTHCARE   ACTAVIS
EQUITY SHARE DATA
    TTK HEALTHCARE
Mar-14
ACTAVIS
Dec-14
TTK HEALTHCARE/
ACTAVIS
5-Yr Chart
Click to enlarge
High Rs66317,418-   
Low Rs39910,625-   
Sales per share (Unadj.) Rs535.63,136.6-  
Earnings per share (Unadj.) Rs15.9-391.4-  
Cash flow per share (Unadj.) Rs20.0287.8-  
Dividends per share (Unadj.) Rs4.000-  
Dividend yield (eoy) %0.80-  
Book value per share (Unadj.) Rs137.66,803.1-  
Shares outstanding (eoy) m7.77265.90-   
Bonus/Rights/Conversions ---  
Price / Sales ratio x1.04.5 22.2%   
Avg P/E ratio x33.3-35.8 -93.0%  
P/CF ratio (eoy) x26.548.7 54.4%  
Price / Book Value ratio x3.92.1 187.3%  
Dividend payout %25.10-   
Avg Mkt Cap Rs m4,1273,728,306 0.1%   
No. of employees `0001.721.6 7.9%   
Total wages/salary Rs m6070-   
Avg. sales/employee Rs Th2,436.738,611.5 6.3%   
Avg. wages/employee Rs Th355.20-   
Avg. net profit/employee Rs Th72.5-4,818.3 -1.5%   
INCOME DATA
Net Sales Rs m4,162834,009 0.5%  
Other income Rs m61-2,082 -2.9%   
Total revenues Rs m4,223831,927 0.5%   
Gross profit Rs m197107,140 0.2%  
Depreciation Rs m32180,593 0.0%   
Interest Rs m3026,306 0.1%   
Profit before tax Rs m197-101,841 -0.2%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m0-7,470 0.0%   
Tax Rs m73-5,236 -1.4%   
Profit after tax Rs m124-104,076 -0.1%  
Gross profit margin %4.712.8 36.9%  
Effective tax rate %37.05.1 719.9%   
Net profit margin %3.0-12.5 -23.9%  
BALANCE SHEET DATA
Current assets Rs m1,629439,416 0.4%   
Current liabilities Rs m1,058320,463 0.3%   
Net working cap to sales %13.714.3 96.2%  
Current ratio x1.51.4 112.3%  
Inventory Days Days3058 51.3%  
Debtors Days Days3466 50.7%  
Net fixed assets Rs m556101,841 0.5%   
Share capital Rs m780-   
"Free" reserves Rs m8780-   
Net worth Rs m1,0691,808,934 0.1%   
Long term debt Rs m159947,917 0.0%   
Total assets Rs m2,3993,315,181 0.1%  
Interest coverage x7.6-2.9 -263.9%   
Debt to equity ratio x0.10.5 28.3%  
Sales to assets ratio x1.70.3 689.5%   
Return on assets %6.4-2.3 -273.2%  
Return on equity %11.6-5.8 -201.4%  
Return on capital %18.5-3.0 -612.9%  
Exports to sales %0.80-   
Imports to sales %1.40-   
Net fx Rs m-300-   
CASH FLOW
From Operations Rs m127143,216 0.1%  
From Investments Rs m-146-342,913 0.0%  
From Financial Activity Rs m22192,667 0.0%  
Net Cashflow Rs m3-7,030 -0.0%  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster
The reporting currency for ACTAVIS (US) is United States Dollars. All data has been converted at 63.85 Rs / USD

Compare TTK HEALTHCARE With: MYLAN (US)  ADCOCK INGRAM (S. Africa)  TEVA PHARMA (Israel)  

Compare TTK HEALTHCARE With: MERCK LTD  AUROBINDO PHARMA  WOCKHARDT LTD.  FRESENIUS KABI ONCO.  IPCA LABS  



Today's Market

Of Global Markets Hitting Record Highs and Top Stocks in Action During the Week(RoundUp)

Global stock markets ended the week on a positive note. Benchmark indices in US grew by 1% during the week. The Down Jones Industrial Average topped the 26,000.

Related Views On News

Sun Pharma: Tough US Scenario Continues to Hit Business (Quarterly Results Update - Detailed)

Nov 20, 2017

The company's India business recovers but the pricing pressure and USFDA issues continue to mar the US revenues.

Dr Reddy's: No Respite from Pricing Pressure in the US (Quarterly Results Update - Detailed)

Nov 13, 2017

Pricing pressure continued to haunt Dr Reddy's although there was a significant improvement in its businesses sequentially.

Cipla: Strong Recovery Post GST (Quarterly Results Update - Detailed)

Nov 10, 2017

Cipla's India business recovers strongly this quarter post the GST issues in the first quarter of this fiscal.

Glenmark: Most Geographies Show Weak Growth (Quarterly Results Update - Detailed)

Nov 7, 2017

Poor show in the US, Latam and India hit profits during the quarter.

Lupin: US Markets Drags down Revenues and Net Profits (Quarterly Results Update - Detailed)

Nov 2, 2017

Domestic markets registers robust growth in the quarter

More Views on News

Most Popular

Retail Investors or Chickens Waiting to Get Slaughtered in the Stock Market?(Vivek Kaul's Diary)

Jan 9, 2018

The price to earnings ratio of the Nifty 50 is very close to all-time high levels.

Best ELSS Funds In 2018: Don't Blindly Chase Top Performers(Outside View)

Jan 10, 2018

As the tax-saving season begins, investors hunt for the best ELSS funds for 2018. PersonalFN provides a list of the top ELSS mutual funds of the past year.

Did GST and Notebandi Help? Sherlock Holmes Finds Out...(The 5 Minute Wrapup)

Jan 13, 2018

Discussions with my cousin helped me understand the situation on Ground Zero - after the demonetization and GST upheaval. Here's what that means for listed companies...

Resolutions for 2018 - by others(The Honest Truth)

Jan 8, 2018

Ten quirky new year resolutions. Guess by whom?

Bitcoin Beginners Should Do These Three Things...(Smart Contrarian)

Jan 10, 2018

Three simple points to keep in mind before you consider buying bitcoin.

More

Small Investments
BIG Returns

Zero To Millions Guide 2018
Get our special report, Zero To Millions
(2018 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

TTK HEALTHCARE SHARE PRICE


Jan 19, 2018 (Close)

TRACK TTK HEALTHCARE

  • Track your investment in TTK HEALTHCARE with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON TTK HEALTHCARE

TTK HEALTHCARE - PIRAMAL ENTERPRISES COMPARISON

COMPARE TTK HEALTHCARE WITH

MARKET STATS